Sympathetic nervous system during converting enzyme inhibition

The American Journal of Medicine

Volumn 87, Issue 6 SUPPL. 2, 1989, Pages 29S-32S

  Crozier, Ian G ^a   Teoh, Robert ^a   Kay, Richard ^a   Nicholls, M Gary ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NORADRENALIN;

ADRENERGIC SYSTEM; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CONFERENCE PAPER; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMAN; HYPERTENSION; NEUROTRANSMITTERS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0024789763     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(89)80925-8     Document Type: Article

References (29)

1. Interaction between sympathetic and reninangiotensin systems
2. Evolution of angiotensin II-induced catecholamine release
3. Angiotensin II augments sympathetically induced venoconstriction in man
4. Evidence in humans for a postsynaptic interaction between noradrenaline and angiotensin II with regard to systolic but not diastolic blood pressure
5. Responsiveness of circulating catecholamines, renin and aldosterone to angiotensin II
6. Lack of response of sympathetic nervous system to angiotensin infusion
7. Evidence against an interaction of angiotensin II with the sympathetic nervous system in man
8. Reduced plasma noradrenaline during angiotensin II-induced acute hypertension in man
9. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man
10. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
11. Effects of the cold pressor test on muscle sympathetic nerve activity in humans
12. Noradrenaline release and sympathetic nervous system activity
13. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity
14. Cardiac and hormonal effects of enalapril in hypertension
15. Influence of sublingual captopril on plasma catecholamine levels during hypertensive emergencies and cold immersion
16. Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside
17. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients
18. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline
19. Enalapril reduces the catecholamine response to exercise in patients with heart failure
20. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study
21. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril
22. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition
23. Efferent pathways of the cardiovascular response to vertebral artery infusions of angiotensin in the dog
24. Mechanisms by which angiotensin II affects the heart rate of the conscious sheep
25. Intravertebral angiotensin II inhibits cardiac vagal efferent activity in dogs
26. Captopril and heart rate
27. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man
28. Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man
29. Severe hypotension after first dose of enalapril in heart failure